Alex Fedotov

532 total citations
2 papers, 12 citations indexed

About

Alex Fedotov is a scholar working on Oncology, Genetics and Biotechnology. According to data from OpenAlex, Alex Fedotov has authored 2 papers receiving a total of 12 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Oncology, 1 paper in Genetics and 1 paper in Biotechnology. Recurrent topics in Alex Fedotov's work include Cancer Treatment and Pharmacology (1 paper), Genomics and Rare Diseases (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). Alex Fedotov is often cited by papers focused on Cancer Treatment and Pharmacology (1 paper), Genomics and Rare Diseases (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). Alex Fedotov collaborates with scholars based in United States. Alex Fedotov's co-authors include Wendy K. Chung, Kathleen A. Leppig, Christin Hoell, Håkon Håkonarson, Margaret Harr, Maureen E. Smith, Eric B. Larson, Ingrid A. Holm, Marc S. Williams and Janet L. Williams and has published in prestigious journals such as Healthcare.

In The Last Decade

Alex Fedotov

1 paper receiving 10 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Fedotov United States 1 10 3 3 2 2 2 12
Helen Coolican Australia 2 11 1.1× 3 1.0× 2 0.7× 3 1.5× 2 1.0× 3 15
Hannah Stark United Kingdom 2 10 1.0× 4 1.3× 2 1.0× 3 1.5× 2 16
Jessica Melin Sweden 3 9 0.9× 3 1.0× 3 1.5× 8 17
Olivia Balderes United States 1 11 1.1× 3 1.0× 3 1.5× 2 17
Amit Khera United States 2 15 1.5× 1 0.3× 3 1.0× 1 0.5× 2 1.0× 4 26
Susan M. Domchek United States 1 4 0.4× 2 0.7× 3 1.0× 1 0.5× 3 10
E.G. Holliday Australia 3 9 0.9× 3 1.0× 1 0.5× 3 17
Beth-Ann Norton United States 2 7 0.7× 2 0.7× 1 0.5× 4 9
Jeffrey Ou United States 2 6 0.6× 1 0.3× 3 1.0× 1 0.5× 1 0.5× 3 12
Photini J. P. McGeorge Greece 3 5 0.5× 2 0.7× 4 14

Countries citing papers authored by Alex Fedotov

Since Specialization
Citations

This map shows the geographic impact of Alex Fedotov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Fedotov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Fedotov more than expected).

Fields of papers citing papers by Alex Fedotov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Fedotov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Fedotov. The network helps show where Alex Fedotov may publish in the future.

Co-authorship network of co-authors of Alex Fedotov

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Fedotov. A scholar is included among the top collaborators of Alex Fedotov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Fedotov. Alex Fedotov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Williams, Janet L., Wendy K. Chung, Alex Fedotov, et al.. (2018). Harmonizing Outcomes for Genomic Medicine: Comparison of eMERGE Outcomes to ClinGen Outcome/Intervention Pairs. Healthcare. 6(3). 83–83. 12 indexed citations
2.
Fedotov, Alex, et al.. (2010). Авастин в лечении метастатического колоректального рака. 9(4).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026